In Other News

• Innovative Combination of Upper-Room GUV Lights and HEPA Filtration Offers Cost-Effective COVID-19 Control Solution for Hospitals

• Machine Learning Tool Gives Early Warning of Cardiac Issues or Blood Clots in COVID Patients

• Johnson & Johnson Single-Dose COVID-19 Vaccine Demonstrates Lasting Immune Response in Early-Stage Trials

• EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

• PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing

• Disposable Helmet Retains Cough Droplets and Decreases Risk of COVID-19 Transmission from Patients

• FDA-Approved Patient Isolation Solution Enables Hospitals to Quickly Set Up Emergency Isolation Rooms for COVID-19 Patients

• New Nanoparticle Immunization Technology Could Protect Against SARS-CoV-2 and Different Coronavirus Variants

• `Immune Cop` Identified in Human Lungs That Detects SARS-CoV-2 Could Help Develop New COVID-19 Treatments

• Ortho's VITROS SARS-CoV-2 Antigen Test Becomes First High-Volume COVID-19 Antigen Test to Receive FDA EUA

• First-of-Its-Kind COVID-19 Lung CT Lesion Segmentation Grand Challenge Unveils Top 10 Results

• Innovative Molecular Detection System Offers On-Site and Rapid Detection of SARS-CoV-2

• Distinct Blood Signatures Found in COVID-19 Patients Could Significantly Improve Testing

• New Simplified Rapid COVID-19 Testing Protocol Requires Less Labor, Expertise and Equipment

• Snibe Diagnostic’s Maglumi SARS-CoV-2 Neutralizing Antibody Assay Receives CE Mark

• COVID-19 Survivors Have Immune Cells Necessary to Fight Re-Infection Until Eight Months, Suggests New Data

• FDA Monitoring Impact of SARS-CoV-2 Mutations on Results of Authorized COVID-19 Molecular Tests

• New Online Risk-Stratification Tool Accurately Predicts Likelihood of Deterioration in Hospitalized COVID-19 Patients

• COVID-19 Test Chip Made by Aerosol Jet Nanoparticle 3D Printing Detects SARS-CoV-2 Antibodies in 10-12 Seconds

• Pfizer-BioNTech COVID-19 Vaccine Effectively Neutralizes Highly Transmissible SARS-CoV-2 Mutations, Finds New Study

• Siemens IL-6 Test for COVID-19 Response Granted FDA Emergency Use Authorization

• Seasonal Coronaviruses Might Stimulate Cross-Protection Against SARS-CoV-2, Finds New Study

• NIH Develops Robust SARS-CoV-2 Serology ELISAs from Serum and Dried Blood Microsamples